Invention Application

NOVEL CTLA4-IG IMMUNOADHESINS
Abstract:
The present application relates to CTLA4-Ig immunoadhesins that target CD80 and CD86, and their use, particularly for therapeutic purposes.
Public/Granted literature
Information query
Patent Agency Ranking
0/0